A study to evaluate the efficacy of test products in hair fall benefits

Phase 3

Completed

• Registration Number: CTRI/2021/02/031378
• Lead Sponsor: Marico Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-12-10
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 161

Inclusion Criteria

1.Male subjectsââ?¬• in general good health.

2.Subjects in the age group 18-40 years (both the ages inclusive).

3.Subjects complaining of hair fall and damage.

4.Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol.

5.Hair density of >100 and <200 hair follicle per square cm as per Trichoscan measurement.

6.Male Subjects falling under Grade 3 - Grade 6 of hair loss severity grade evaluated as per photo numerical 10-point scale (Linear scale for assessment purpose-In Use Scale).

7.Subjects who are willing to give their hair samples for assessments.

Exclusion Criteria

1.Subjects who have undergone hair growth treatment within 3 months before screening into the study.

2.Subjects having any active scalp disease which may interfere in the study ââ?¬â?? dermatologistââ?¬•s judgement.

3.Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.

4.Subjects who have history of alcoholism, smoking, crash dieting and/ or psychiatric disorder including trichotillomania.

5.Subjects who have had hair transplant, who have taken pharmaceutical product which cause hirsutism (ex. phenytoin) and finesteride for androgenic alopecia, under medical treatment for hair problems.

6.A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.

7.Subjects on oral medications, undergoing any chemical hair salon treatment-straightening / perming / colour/ henna which will compromise the study.

8.Subjects with chronic illness which may influence the cutaneous state.

9.Subjects participating in other similar cosmetic or therapeutic trial within last three months.

10.Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified